How disclosure laws really impact drug prices
Ginger Scanlon (PhD ’25) researches the effectiveness of disclosure regulation in reducing drug costs for patients and health plans.
Research is key to how we make good on our promise to prepare students and executives for tomorrow’s business world. Our professors examine critical issues influencing 21st century business – you benefit from their insights in the classroom and the boardroom. Contributing to the breadth and depth of our thought leadership are our Frank Hawkins Kenan Institute of Private Enterprise and centers.